8-K: Altria Group Releases 2023 Financial Results, Completes NJOY Acquisition

Altria Group reports its financial results for 2023, highlighting the acquisition of NJOY and its impact on the company's financials.

Summary

• Altria Group, Inc. has released its consolidated financial statements for the year ended December 31, 2023, including balance sheets, statements of earnings, comprehensive earnings, stockholders' equity, and cash flows.
• The company completed the acquisition of NJOY Holdings, Inc. on June 1, 2023, for approximately $2.9 billion, which included $2.75 billion in cash and up to $500 million in contingent payments.
• Altria's net revenues for 2023 were $24.483 billion, compared to $25.096 billion in 2022 and $26.013 billion in 2021.
• Net earnings for 2023 were $8.130 billion, a significant increase from $5.764 billion in 2022 and $2.475 billion in 2021.
• Basic and diluted earnings per share were $4.57 in 2023, compared to $3.19 in 2022 and $1.34 in 2021.
• The company repurchased $1.0 billion of its common stock in 2023 and authorized a new $1.0 billion share repurchase program for 2024.
• Altria's investment in Anheuser-Busch InBev (ABI) is valued at $12.7 billion, exceeding its carrying value by approximately 32%.
• The company recorded a non-cash, pre-tax loss of $250 million on the disposition of its JUUL equity securities.

Sentiment

Score: 7

Explanation: The document presents a mixed picture with strong earnings and strategic acquisitions offset by revenue declines and litigation risks. The overall sentiment is cautiously optimistic.

Positives

• The acquisition of NJOY provides Altria with a strong position in the e-vapor market.
• Net earnings showed a significant increase in 2023, indicating improved profitability.
• The company's share repurchase programs demonstrate a commitment to returning value to shareholders.
• The fair value of the ABI investment significantly exceeds its carrying value, suggesting a strong asset.
• Altria has a strong cash position with $3.686 billion in cash and cash equivalents at the end of 2023.

Negatives

• Net revenues decreased slightly in 2023 compared to 2022 and 2021.
• The company recorded a $250 million loss on the disposition of its JUUL investment.
• Total liabilities increased from $40.877 billion in 2022 to $42.060 billion in 2023.
• The company has a negative total stockholders equity (deficit) of $3.490 billion at the end of 2023.

Risks

• The company faces ongoing litigation risks, particularly in tobacco and health-related cases.
• The tobacco industry is subject to regulatory changes and public health concerns that could impact future performance.
• The company's investments in equity securities, such as ABI and Cronos, are subject to market fluctuations and potential impairments.
• The integration of NJOY may present challenges and require significant management attention.
• The company's debt levels are significant, with long-term debt of $25.112 billion at the end of 2023.

Future Outlook

The company expects to complete a $1.0 billion share repurchase program by December 31, 2024. Future dividend payments remain subject to the discretion of the Board.

Industry Context

The acquisition of NJOY reflects a broader trend in the tobacco industry towards diversification into alternative nicotine products, as traditional cigarette sales decline. This move positions Altria to compete in the growing e-vapor market.

Comparison to Industry Standards

• Altria's performance is being compared to other major tobacco companies such as Philip Morris International (PMI) and British American Tobacco (BAT).
• The acquisition of NJOY is similar to BAT's investment in e-cigarette brands, indicating a strategic shift in the industry.
• Altria's revenue decline is consistent with the overall trend of decreasing cigarette sales, but its profitability is higher than some competitors due to cost management and strategic investments.
• The company's share repurchase program is a common practice among large, mature companies in the tobacco sector to return value to shareholders.
• The litigation risks faced by Altria are similar to those faced by other major tobacco companies, highlighting the industry's exposure to legal challenges.

Legal Proceedings

• The company is involved in numerous legal proceedings, including tobacco and health-related litigation, e-vapor product litigation, and antitrust litigation.
• Altria is a defendant in 57 class action lawsuits, 3,614 individual lawsuits and 1,506 third party lawsuits relating to JUUL e-vapor products.
• The company has reached a settlement to resolve the majority of the Multidistrict Litigation lawsuits for $235 million.
• Altria is involved in ongoing disputes related to the Master Settlement Agreement (MSA) and Non-Participating Manufacturer (NPM) adjustments.

Stakeholder Impact

• Shareholders will benefit from the share repurchase program and increased earnings.
• Employees may be impacted by the integration of NJOY and any changes in business strategy.
• Customers will have access to a broader range of products, including e-vapor options.
• Suppliers may be affected by changes in the company's supply chain and procurement practices.
• Creditors will be interested in the company's debt levels and ability to meet its obligations.

Next Steps

• The company will complete the $1.0 billion share repurchase program by December 31, 2024.
• Altria will continue to integrate NJOY into its operations.
• The company will continue to defend against ongoing litigation.

Key Dates

Keywords

Altria, NJOY, Financial Results, Acquisition, E-vapor, Tobacco, Share Repurchase, Earnings Per Share, Litigation, ABI, JUUL